In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data

References

• Savarese G, Lund LH. Global public health burden of heart failure. Heart Fail Rev. 2017;3(1):7–11. doi:10.15420/cfr.2016:25:2
   Google Scholar
• Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC Heart Failure. 2014;1(1):4–25. doi:10.1002/ehf2.12005
   PubMedGoogle Scholar
• Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137–1146. doi:10.1136/hrt.2003.025270
   PubMed Web of Science ®Google Scholar
• Li H, Hastings MH, Rhee J, Trager LE, Roh JD, Rosenzweig A. Targeting age-related pathways in heart failure. Circ Res. 2020;126(4):533–551. doi:10.1161/CIRCRESAHA.119.315889
   PubMed Web of Science ®Google Scholar
• Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O’Connor CM. Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail. 2013;15(7):717–723. doi:10.1093/eurjhf/hft028
   PubMed Web of Science ®Google Scholar
• Nakatani H. Population aging in Japan: policy transformation, sustainable development goals, universal health coverage, and social determinates of health. Global Health is J. 2019;1(1):3–10. doi:10.35772/ghm.2019.01011
   Google Scholar
• Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015;17(9):884–892. doi:10.1002/ejhf.319
   PubMed Web of Science ®Google Scholar
• Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J. 2008;72(3):489–491. doi:10.1253/circj.72.489
   PubMed Web of Science ®Google Scholar
• Takabayashi K, Kitaguchi S, Yamamoto T, et al. Mode of death in elderly and super-elderly patients with acute heart failure: insights from Japanese heart failure registry. Clin Cardiol. 2021;44(6):848–856. doi:10.1002/clc.23619
   PubMed Web of Science ®Google Scholar
• Kanaoka K, Okayama S, Nakai M, et al. Hospitalization costs for patients with acute congestive heart failure in Japan. Circ J. 2019;83(5):1025–1031. doi:10.1253/circj.CJ-18-1212
   PubMed Web of Science ®Google Scholar
• Sasaki N, Kunisawa S, Ikai H, Imanaka Y. Differences between determinants of in-hospital mortality and hospitalisation costs for patients with acute heart failure: a nationwide observational study from Japan. BMJ Open. 2017;7(3):e013753. doi:10.1136/bmjopen-2016-013753
   PubMed Web of Science ®Google Scholar
• Adamo M, Alos B, Metra M, et al. Patient with heart failure: importance to treat valvular diseases. Eur Heart J. 2020;22(Supplement_P):P38–P41. doi:10.1093/eurheartj/suaa184
   Web of Science ®Google Scholar
• Falk V, Baumgartner H, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2017;52(4):616–664. doi:10.1093/ejcts/ezx324
   PubMed Web of Science ®Google Scholar
• Ide T, Kaku H, Matsushima S, et al. Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF). Circ J. 2021;85(9):1438–1450. doi:10.1253/circj.CJ-20-0947
   PubMed Web of Science ®Google Scholar
• Bartko PE, Heitzinger G, Pavo N, et al. Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ. 2021;373:n1421. doi:10.1136/bmj.n1421
   PubMedGoogle Scholar
• Gevaert AB, Tibebu S, Mamas MA, et al. Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes. ESC Heart Failure. 2021;8(4):2741–2754. doi:10.1002/ehf2.13344
   PubMed Web of Science ®Google Scholar
• Koyama T. Trends in surgical treatment for valvular heart disease in Japan. J St Marianna Univer. 2021;12(1):19–28. doi:10.17264/stmarieng.12.19
   Google Scholar
• Campo J, Tsoris A, Kruse J, et al. Prognosis of severe asymptomatic aortic stenosis with and without surgery. Ann Thorac Surg. 2019;108(1):74–79. doi:10.1016/j.athoracsur.2019.01.031
   PubMed Web of Science ®Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e72–e227. doi:10.1161/CIR.0000000000000923
   PubMed Web of Science ®Google Scholar
• Clark MA, Arnold SV, Duhay FG, et al. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circ Cardiovasc Qual Outcomes. 2012;5(5):697–704. doi:10.1161/circoutcomes.112.966002
   PubMed Web of Science ®Google Scholar
• Saia F, Loforte A, Pacini D. Innovative transcatheter procedures for the treatment of heart failure. Cardiovasc Diagn Ther. 2021;11(1):292–300. doi:10.21037/cdt-20-335
   PubMed Web of Science ®Google Scholar
• Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: a review. JAMA. 2021;325(24):2480–2494. doi:10.1001/jama.2021.2133
   PubMed Web of Science ®Google Scholar
• Izumi C, Eishi K, Ashihara K, et al. JCS/JSCS/JATS/JSVS 2020 Guidelines on the management of valvular heart disease. Circ J. 2020;84(11):2037–2119. doi:10.1253/circj.CJ-20-0135
   PubMed Web of Science ®Google Scholar
• Chung CH, Wang YJ, Lee CY. Epidemiology of heart valve disease in Taiwan. Int Heart J. 2021;62(5):1026–1034. doi:10.1536/ihj.21-044
   PubMed Web of Science ®Google Scholar
• Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease. Circulation. 2019;140(14):1156–1169. doi:10.1161/CIRCULATIONAHA.119.041080
   PubMed Web of Science ®Google Scholar
• Brennan JM, Lowenstern A, Sheridan P, et al. Association between patient survival and clinician variability in treatment rates for aortic valve stenosis. J Am Heart Assoc. 2021;10(16):e020490. doi:10.1161/JAHA.120.020490
   PubMed Web of Science ®Google Scholar
• Hayashida K, Murakami G, Matsuda S, Fushimi K. History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan. J Epidemiol. 2021;31(1):1–11. doi:10.2188/jea.JE20200288
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Ide T, Ito H, et al. JCS/JHFS 2021 Guideline focused update on diagnosis and treatment of acute and chronic heart failure. Circ J. 2021;85(12):2252–2291. doi:10.1253/circj.CJ-21-0431
   PubMed Web of Science ®Google Scholar
• Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, et al. Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure-A report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). J Cardiol. 2013;62(2):95–101. doi:10.1016/j.jjcc.2013.03.009
   PubMed Web of Science ®Google Scholar
• Sato N, Kajimoto K, Keida T, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J. 2013;77(4):944–951. doi:10.1253/circj.cj-13-0187
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Kohsaka S, Sato N, et al. 9-Year trend in the management of acute heart failure in Japan: a report from the national consortium of acute heart failure registries. J Am Heart Assoc. 2018;7(18):e008687. doi:10.1161/jaha.118.008687
   PubMed Web of Science ®Google Scholar
• Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular heart disease epidemiology. J Med Sci. 2022;10(2):32. doi:10.3390/medsci10020032
   Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011. doi:10.1016/s0140-6736(06)69208-8
   PubMed Web of Science ®Google Scholar
• Kodali SK, Velagapudi P, Hahn RT, Abbott D, Leon MB. Valvular heart disease in patients ≥80 years of age. J Am Coll Cardiol. 2018;71(18):2058–2072. doi:10.1016/j.jacc.2018.03.459
   PubMed Web of Science ®Google Scholar
• Mitani H, Funakubo M, Sato N, et al. In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: a Japanese database cohort study. J Cardiol. 2020;76(4):342–349. doi:10.1016/j.jjcc.2020.05.010
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. FY2020 medical expenses, etc. by hospital function and system. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/iryouhoken/database/zenpan/topics_r03.html. Accessed September 28, 2022.
   Google Scholar
• Fukuda H, Kiyohara K, Sato D, Kitamura T, Kodera S. A real-world comparison of 1-year survival and expenditures for transcatheter aortic valve replacements: SAPIEN 3 versus CoreValve versus Evolut R. Value Health. 2021;24(4):497–504. doi:10.1016/j.jval.2020.10.022
   PubMed Web of Science ®Google Scholar
• Kamon T, Kaneko H, Kiriyama H, et al. Transcatheter aortic valve implantation and surgical aortic valve replacement for aortic stenosis in Japan: analysis of a nationwide inpatient database. Circ Rep. 2020;2(12):753–758. doi:10.1253/circrep.CR-20-0116
   PubMedGoogle Scholar
• Sakamaki H, Nakao K, Matsumoto T, Inoue S. Cost-effectiveness analysis of percutaneous mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation in Japan. J Med Econ. 2019;22(12):1312–1320. doi:10.1080/13696998.2019.1668132
   PubMed Web of Science ®Google Scholar
• Saku K, Yokota S, Nishikawa T, Kinugawa K. Interventional heart failure therapy: a new concept fighting against heart failure. J Cardiol. 2022;80(2):101–109. doi:10.1016/j.jjcc.2021.11.018
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Iung B, Otto CM. Timing of intervention in asymptomatic patients with valvular heart disease. Eur Heart J. 2020;41(45):4349–4356. doi:10.1093/eurheartj/ehaa485
   PubMed Web of Science ®Google Scholar
• Cameli M, Sciaccaluga C, Mandoli GE, D’Ascenzi F, Tsioulpas C, Mondillo S. The role of the left atrial function in the surgical management of aortic and mitral valve disease. Echocardiography. 2019;36(8):1559–1565. doi:10.1111/echo.14426
   PubMed Web of Science ®Google Scholar
• Sonaglioni A, Nicolosi GL, Rigamonti E, Lombardo M. Incremental prognostic role of left atrial reservoir strain in asymptomatic patients with moderate aortic stenosis. Int J Card Imaging. 2021;37(6):1913–1925. doi:10.1007/s10554-021-02175-6
   PubMed Web of Science ®Google Scholar
• Inoue S, Nakao K, Hanyu M, et al. Cost-effectiveness of transcatheter aortic valve implantation using a balloon-expandable valve in Japan: experience from the Japanese pilot health technology assessment. Value Health Reg Issues. 2020;21:82–90. doi:10.1016/j.vhri.2019.07.013
   PubMedGoogle Scholar
• Nishi H, Miyata H, Motomura N, et al. Propensity-matched analysis of minimally invasive mitral valve repair using a nationwide surgical database. Surg Today. 2015;45(9):1144–1152. doi:10.1007/s00595-015-1210-7
   PubMed Web of Science ®Google Scholar
• Laurent T, Simeone J, Kuwatsuru R, et al. Context and considerations for use of two Japanese real-world databases in Japan: medical data vision and Japanese medical data center. Drugs Real World Outcomes. 2022;9(2):175–187. doi:10.1007/s40801-022-00296-5
   PubMedGoogle Scholar